The latest price target for Steris (NYSE:STE) was reported by JMP Securities on February 6, 2025. The analyst firm set a price target for $265.00 expecting STE to rise to within 12 months (a possible 19.49% upside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for Steris (NYSE:STE) was provided by JMP Securities, and Steris reiterated their market outperform rating.

The last upgrade for Steris PLC happened on October 24, 2024 when Piper Sandler raised their price target to $260. Piper Sandler previously had a neutral for Steris PLC.

The last downgrade for Steris PLC happened on April 14, 2023 when Piper Sandler changed their price target from $215 to $197 for Steris PLC.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Steris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Steris was filed on February 6, 2025 so you should expect the next rating to be made available sometime around February 6, 2026.

While ratings are subjective and will change, the latest Steris (STE) rating was a reiterated with a price target of $265.00 to $265.00. The current price Steris (STE) is trading at is $221.78, which is out of the analyst’s predicted range.